Model Viruses

The selection of model viruses for the purpose of validation is critical and must take into account the nature and origin of the producer cell line; the model virus should be close to identical to a virus suspected in the cell line, or closely related to viruses that might infect the cell, e.g. retroviruses for recombinant or hybridoma cells.

In order to achieve a maximum reduction factor for virus, the model virus should be grown to high titers and should be detectable in a simple but sensitive assay. Care has to be taken when concentrating a virus solution in order to increase the volumetric titer: the aggregation of viral particles might lead to an increased but not relevant mechanical removal by means of filtration, or a decrease in inactivation due to protection of viral particles in the core of the aggregate.

Typically, the removal or inactivation of virus is described as "log 10 reduction", i.e. the decadic logarithm of the titer reduction.

With regard to a potential infection by an unknown virus, the model viruses for the validation of virus clearance have to cover a broad range of virus features.

Virus Features Feasibility
size and shape of virus

enveloped/non-enveloped

genome structure DNA/RNA

strandedness of genome

resistance to inactivation

relevance for production

achievable high tier

high sensitivity of detection

ease of detection

Selection criteria for the choice of model viruses

Virus

Family

Genus

Natural host

Genome

Envelope

Size

Shape

Resis-

tance

Vesicular stomatitis virus

Rhabdo

Vesiculo-virus

Equine

Bovine

RNA

yes

70x175 nm

Bullet

Low

Parainfluenza virus

Paramyxo

Paramyxo-virus

Various

RNA

yes

100-200+ nm

Pleomorph
Spherical

Low

MuLV

Retro

Type C oncovirus

Mouse

RNA

yes

80 - 110 nm

Spherical

Low

Sindbis virus

Toga

Alphavirus

Human

RNA

yes

60 - 70 nm

Spherical

Low

BVDV

Flavi

Pestivirus

Bovine

RNA

yes

50 - 70 nm

Pleomorph
Spherical

Low

Pseudorabies

Herpes

 

Swine

DNA

yes

120 - 200 nm

Spherical

Medium

Poliovirus Sabin

Type 1

Picorna

Enterovirus

Human

RNA

no

25 - 30 nm

Icosahedral

Medium

Encephalomyo-

carditis virus (EMC)

Picorna

Cardiovirus

Mouse

RNA

no

25 - 30 nm

Icosahedral

Medium

Reovirus 3

Reo

Orthoreo-

virus

Various

RNA

no

60 - 80 nm

Spherical

Medium

SV 40

Papova

Polyoma-

virus

Monkey

DNA

no

40 -50 nm

Icosahedral

Very

high

Paroviruses

(canine, porcine)

Parvo

Parvo-

virus

Canine

Porcine

DNA

no

18-24 nm

Icosahedral

Very

high

Selection of model viruses for validation studies

Resistance to physico-chemical treatments based on studies of production processes. Resistance is relative to the specific treatment and it is used in the context of the understanding of the biology of the virus and the nature of the manufacturing process. Actual results will vary according to the treatment. These viruses are examples only and their use is not mandatory [from: ICH Q5A].

As a rule process validation has to be performed at the manufacturing scale, using equipment of identical type and size. The contamination of manufacturing equipment with virus is evidently not desireful and depending on the manufacturing scale even not technically feasible. Therefore two strategies are accepted for the validation work with virus:
More About Validation
  • Validation Procedures
  • Validation of Viral Clearance
  • Calculation of the Clearance Factor
    • the use of a replica for a small scale production or
    • a linear downscaled model of the manufacturing equipment, on condition that all relevant process parameters are fully representative for the production scale.

    ©1999 Charm Bioengineering, Inc.